| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3945804 | Gynecologic Oncology | 2010 | 6 Pages |
Abstract
Gefitinib, administered in combination with paclitaxel and carboplatin, provides a good clinical response but associated with an increased risk of hematologic disorders.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Patricia Pautier, Florence Joly, Pierre Kerbrat, Philippe Bougnoux, Pierre Fumoleau, Thierry Petit, Olivier Rixe, François Ringeisen, Annie Tisseron Carrasco, Catherine Lhommé,